EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

HIV-1 Myeloid Reservoirs — Contributors to Viral Persistence and Pathogenesis

Edna A Ferreira, Janice E Clements, Rebecca T Veenhuis

Current HIV/AIDS Reports · 2024-04 · 21 (2) · 62-74

DOI: 10.1007/s11904-024-00692-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current HIV/AIDS Reports, online erschienen am 27.02.2024. Verfasst von Edna A Ferreira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA. Hauptthemen laut MEDLINE: HIV Infections, Simian Acquired Immunodeficiency Syndrome, HIV-1, Simian Immunodeficiency Virus. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: HIV reservoirs are the main barrier to cure. CD4+ T cells have been extensively studied as the primary HIV-1 reservoir. However, there is substantial evidence that HIV-1-infected myeloid cells (monocytes/macrophages) also contribute to viral persistence and pathogenesis. RECENT FINDINGS: Recent studies in animal models and people with HIV-1 demonstrate that myeloid cells are cellular reservoirs of HIV-1. HIV-1 genomes and viral RNA have been reported in circulating monocytes and tissue-resident macrophages from the brain, urethra, gut, liver, and spleen. Importantly, viral outgrowth assays have quantified persistent infectious virus from monocyte-derived macrophages and tissue-resident macrophages. The myeloid cell compartment represents an important target of HIV-1 infection. While myeloid reservoirs may be more difficult to measure than CD4+ T cell reservoirs, they are long-lived, contribute to viral persistence, and, unless specifically targeted, will prevent an HIV-1 cure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsSimian Acquired Immunodeficiency SyndromeHIV-1Simian Immunodeficiency VirusHIV SeropositivityAnimalsHumansMacrophagesCD4-Positive T-LymphocytesVirus LatencyViral Load

Stichwörter der Autor:innen

HIV-1 pathogenesisHIV-1 persistenceHIV-1 reservoirMacrophagesMonocytesSIV reservoir

Autor:innen und Institutionen

  • Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.
  • Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA. rterill1@jh.edu.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA. rterill1@jh.edu.

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Ferreira, E. A., Clements, J. E., & Veenhuis, R. T. (2024). HIV-1 Myeloid Reservoirs — Contributors to Viral Persistence and Pathogenesis. Current HIV/AIDS Reports, 21(2), 62-74. https://doi.org/10.1007/s11904-024-00692-2

Vancouver

Ferreira EA, Clements JE, Veenhuis RT. HIV-1 Myeloid Reservoirs — Contributors to Viral Persistence and Pathogenesis. Current HIV/AIDS Reports. 2024;21(2):62-74. doi:10.1007/s11904-024-00692-2

BibTeX
@article{Ferreira2024,
  author = {Ferreira, Edna A and Clements, Janice E and Veenhuis, Rebecca T},
  title = {HIV-1 Myeloid Reservoirs — Contributors to Viral Persistence and Pathogenesis},
  journal = {Current HIV/AIDS Reports},
  year = {2024},
  volume = {21},
  number = {2},
  pages = {62--74},
  doi = {10.1007/s11904-024-00692-2}
}
Kostenlos starten →